Acute pancreatitis (AP) is one of the most common disorders of the gastrointestinal tract to result in hospitalization. Although most patients with AP will experience an uneventful disease course, those that develop moderate-to-severe AP can be challenging to manage.
[lire la quatrième du livre Acute and Recurrent Pancreatitis]
This is the tenth edition of this Fast Facts handbook since the firstwas published in 1996 – the many iterations are testament to the rapidchanges in the field and steadily improving outlook for patients. Thisnew edition introduces the Gleason grade grouping (Chapter 1), whichhas important prognostic value, and nomograms that are used toevaluate risk (Chapter 3).
[lire la quatrième du livre Prostate Cancer]
Using real examples from oncology trials, but keeping it simple, this concise resource explains the basic principles of medical statistics so that you can better appraise clinical trial results.
[lire la quatrième du livre Medical Statistics]
Technology is changing how we practice medicine. Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use.
[lire la quatrième du livre Digital Medicine]
Gene therapy has emerged as a discipline in medicine that can provide treatments for diseases that have no other therapies available, save lives of patients for whom there is no other hope and replace suboptimal treatments with lasting cures.
[lire la quatrième du livre Gene therapy]
Thrombotic thrombocytopenic purpura (TTP) is a rare disorder of the blood coagulation system. In most cases, a lack of the ADAMTS13 enzyme leads to an accumulation of ultra-large von Willebrand factor molecules in the plasma which, in turn, initiate the formation of microscopic thromboses in small blood vessels. TTP is a medical emergency.
[lire la quatrième du livre Thrombotic Thrombocytopenic Purpura]
Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics.
[lire la quatrième du livre Biosimilars in Hematology and Oncology]
Asthma is a long-term condition that reduces the amount of air flowing in and out of the lungs. Whether your symptoms are mild, difficult-to-control or severe, it is important to be in control of your asthma. The information in this booklet is designed to help you and your family better understand the condition, what triggers it and how to treat it.
[lire la quatrième du livre Asthma]
Fast Facts: Advanced Cutaneous Squamous Cell Carcinoma' is for people who have or may have advanced cutaneous squamous cell carcinoma. It aims to help patients, and people close to them, understand the condition so they can have better discussions with the cancer team. Decisions about treatment and next steps are highly individual.
[lire la quatrième du livre Advanced Cutaneous Squamous Cell Carcinoma]
A diagnosis of amyotrophic lateral sclerosis (also known as Lou Gehrig’s disease or motor neuron disease) is a progressive neurodegenerative disorder that exerts a notorious life-shortening physical toll.
[lire la quatrième du livre Diagnosing amyotrophic lateral sclerosis]
Inflammatory bowel disease (IBD) is in fact two long-term conditions – ulcerative colitis or Crohn’s disease – that cause problems in the digestive system. No two patients with IBD have the same experience. How the disease progresses, the type of complications and the response to treatment all differ from person to person.
[lire la quatrième du livre Inflammatory Bowel Disease]
The peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified, accurate diagnosis remains challenging, requiring careful, expert integration of the clinical and pathological findings.
The treatment of PTCL is also challenging.
[lire la quatrième du livre Peripheral T-cell Lymphoma]
Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as monotherapies and in combination. Adverse events tend to be mild to moderate, but they can be severe or even life-threatening. Prompt recognition and effective management are vital.
[lire la quatrième du livre Managing immune-related adverse events in oncology]
Although dopaminergic medication is the most effective treatment for patients with Parkinson’s disease (PD), its long-term use is associated with debilitating motor fluctuations. Patients may not spontaneously seek assistance when fluctuations develop, so strategies need to be put in place to identify and alleviate motor dysfunction.
[lire la quatrième du livre Treatment optimization of motor fluctuations in [...]]
This last year has seen the approval of the first targeted treatments for acute myeloid leukemia (AML) - following decades with no new developments and a poor prognosis for most patients with the disease.
[lire la quatrième du livre Acute myeloid leukemia]
Lymphoma affects all ages. Advances in diagnostic cellular and molecular techniques coupled with new treatment options are improving patient outcomes.
[lire la quatrième du livre Lymphoma]
